Graduate Student Research Achievements Site
日本語>>
TOP page
TOP page
> SAKAI Ryuutaro
（Last updated : 2026-09-30 13:45:12）
SAKAI Ryuutaro
Department / Course
Ritsumeikan University Graduate School Graduate School of Life Sciences Major in Advanced Life Sciences
Job
research
Books and theses
Profile
Academic conference attendance and presentation
Others
Graduate Students' Project and Research Society
Graduate Students' Project and Research Society Link
Study Abroad and Overseas Travel History
Internship History
Other Research Achievements
Teaching Assistant
Research Assistant
Research Fellowships for Young Scientists
Skills
Desired Course
Free Entry
Internal Scholarship and Research Grants receiving status
Self and Research introduction
External Scholarship and Research Grants receiving status
Books and theses
Papers
HEALTH ECONOMIC EVALUATION MODEL FOR BREAST CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) VALUE IN HEALTH 28 (12) (Co-authored) 2025/12
Papers
HEALTH ECONOMIC EVALUATION MODEL FOR OVARIAN CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) VALUE IN HEALTH 28 (12) (Co-authored) 2025/12
Papers
HEALTH ECONOMIC EVALUATION MODEL FOR PANCREATIC CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) VALUE IN HEALTH 28 (12) (Co-authored) 2025/12
Papers
HEALTH ECONOMIC EVALUATION MODEL FOR PROSTATE CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) VALUE IN HEALTH 28 (12) (Co-authored) 2025/12
Academic conference attendance and presentation
2026/09/08
Health Economic Evaluation of Pancreatic Cancer Risk Control Using Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) in BRCA1/2 Pathogenic Variant Carriers (International Society for Pharmacoeconomics and Outcomes Research（ISPOR）)
2026/09/07
Cost-Effectiveness Analysis of Atezolizumab plus Bevacizumab Combination Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma (International Society for Pharmacoeconomics and Outcomes Research（ISPOR）)
2026/09/07
Health Economic Evaluation Model for Breast Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) in BRCA1/2 Pathogenic Variant Carriers (International Society for Pharmacoeconomics and Outcomes Research（ISPOR）)
2025/11/09
Health Economic Evaluation Model for Breast Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) (International Society for Pharmacoeconomics and Outcomes Research（ISPOR）)
2025/11/09
Health Economic Evaluation Model for Ovarian Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) (International Society for Pharmacoeconomics and Outcomes Research（ISPOR）)
Display All（8）